Navigation Links
Exubera could mean the end of an insulin injection era for diabetics

Diabetes and cancer remain the most feared diseases all around the world. Researchers have now come up with an insulin inhaler, potentially offering adult diabetics an alternative to injections// for controlling their blood sugar. The drug is yet to be approved by the FDA.

If approved, the drug, known as Exubera, would mean an end to the insulin injections taken by millions worldwide. The product works by releasing an insulin-powder cloud inhaled via a handheld plastic machine similar to the inhalers used for asthma and allergy. The drug has been in development for a decade and is now backed by a joint venture between Pfizer, Sanofi-Aventis and Nektar Therapeutics.

Pfizer presented several studies showing Exubera controlled blood sugar as well as insulin shots for up to two years in patients with both forms of diabetes. Questions remain about whether adult Type 1 diabetics can expect to achieve tight glycemic control with Exubera.

Up to two-thirds of all diabetics do not adequately control their blood sugar, according to the American Academy of Clinical Endocrinologists. Poor control over the long term can lead to blood vessel and organ damage, blindness, and kidney failure and foot ailments.

Despite approval, many would still have to use needles, because the drug is not a replacement for the currently available longer-acting insulin. In addition, patients who smoke will be excluded from taking the drug, because of evidence that damage from cigarettes boosts patients` exposure to insulin.

'To have people rush to the this product saying, `I can throw away my syringes` ... is simply an incorrect message and that needs to be emphasized more,' said Dr. Paul D. Woolf, chief of medicine at Crozer Chester Medical Center in Upland, Pa., and acting chair of the advisory panel. I think the use of insulin without a needle, the siren call of that is almost irresistible,' said Rebecca W. Killion, the panel`s patient representative --
'"/>




Page: 1 2

Related medicine news :

1. New Drug Exubera (Oral Inhaled Insulin) To Be Monitored By Pfizer
2. Exubera is effective in diabetes patients with cold or flu
3. Virus Level could Predict Cervical Cancer Risk
4. Beware of the oral patch! It could be cancer!!!
5. Prozac miracle could end in disaster
6. Wonder drug - could end in disaster
7. Pollution could be a risk
8. Fright could be more harmful
9. Pregnant smokers could harm their child
10. Snoring could be a warning
11. Anthrax drug doxycycline could stunt fetal growth

Post Your Comments:
(Date:11/30/2009)...d, Nov. 30 Tyco Internat... 2010 annual general meeting of shareholders will ...Central European time at the Park Hyatt Zurich Hot.... Registered shareholders as of January 11, 2010 (...nnual general meeting. Additionally, individuals ...
(Date:11/30/2009)...ent and extensive discussion in the scientific com...n Health Care (IQWiG) presents its methods for eva... Institute can now apply these methods when workin...int Committee (G-BA). The method developed by IQWi...e GKV-Spitzenverband [National Association of Heal...
(Date:11/30/2009)... Reportlinker.com announces that a ...alogue: ,, Key Players and Innovative Start-Up...ients, pharma, food and drinks ,, http://www....ve-Start-Ups-in-Nutraceuticals-Emerging-strategies... Nutraceuticals are bioactive compounds with prope...
(Date:11/30/2009)... 30 American Diversified...ed to announce the appointment of Howard M. McEld... Board of Directors. Mr. McEldowney, whose investm... the Chemical Bank in New York City and subsequent...ldowney, San Francisco, an institutional money man...
(Date:11/30/2009)...ogy (EAU) and Europa Uomo, the European,advocacy ...ve entered into an,affiliated partnership as part...rove,patient awareness in Europe with regards to ...amsson, Secretary-General of the EAU: "Thanks to t...o will gain access to the latest information on,o...
Breaking Medicine News(10 mins):Health News:IQWiG presents a method for evaluating the relation between cost and benefit 2Health News:IQWiG presents a method for evaluating the relation between cost and benefit 3Health News:IQWiG presents a method for evaluating the relation between cost and benefit 4Health News:IQWiG presents a method for evaluating the relation between cost and benefit 5Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 2Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 3Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 4Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 5Health News:Reportlinker Adds Key Players and Innovative Start-Ups in Nutraceuticals: Emerging Strategies in Ingredients, Pharma, Food and Drinks 6Health News:American Diversified Holdings Corporation Announces Appointment of Independent Director to the Board of the Company 2
... Israel, May 5 Lumenis Ltd. announced plans to,al...nis Vision) for,aggressive growth while at the sam...nd reliability., Lumenis, Ophthalmic Unit has bee...nt for Business Development, and,will replace Mr. ...
...ULU, MAY 5, 2008 Two scientists who helped explai...nd other organs have been chosen to receive the 20... , Philip A. Beachy, PhD, and Clifford J. Tabin,...gnals guide the formation of the brain, limbs, spi...
...L HILL Parents of children with autism were rough... mental disorder, such as schizophrenia, than pare... Swedish birth and hospital records by a Universit...sm spectrum disorders in the offspring, appears in...
...China, May 4 /Xinhua-PRNewswire-FirstCall/ -- Chin...r "the Company") (OTC Bulletin,Board: CSKI), a lea...xternal use, over-the-counter drugs in the People,...Harbin First Bio-Engineering Company Limited ("Fir...
...e sequence linked to an expanding waist line, weig...has been discovered as part of a study published t... also shows that the gene sequence is significantl...ways of treating obesity. , Scientists from Imper...
...c Society Elects Top Officers at 2008 Annual Meeti...astic surgeon,Alan H. Gold, MD, is the new Preside...urgery (ASAPS). The Aesthetic Society, with nearly...ection of new officers was held on May 4, during t...
Other Medicine News:Health News:Lumenis Announces changes in Lumenis Vision Strategic Business Unit 2Health News:March of Dimes awards $250,000 prize to leaders in understanding embryonic development 2Health News:Mental disorders in parents linked to autism in children 2Health News:China Sky One Medical, Inc. Successfully Develops Semi-Quantitative Automatic Inspection Device for Diagnostic Kits 2Health News:China Sky One Medical, Inc. Successfully Develops Semi-Quantitative Automatic Inspection Device for Diagnostic Kits 3Health News:Gene sequence that can make half of us fatter is discovered 2Health News:Long Island Plastic Surgeon is New President of American Society for Aesthetic Plastic Surgery 2Health News:Long Island Plastic Surgeon is New President of American Society for Aesthetic Plastic Surgery 3
(Date:11/30/2009)... N.J., Nov. 30 MedQu...echnology-enabled clinical documentation services,...ological Society of North America (RSNA) conferenc... the product leverages SpeechQ(TM), the company,s ...on used by thousands of radiologists. MedQuist ha...
(Date:11/30/2009)...alif., Nov. 30 StemCyte, Inc. conc...greement with Academia Sinica, the National Labora...d Intellectual Property (IP) related to the treatm...d and IP was pioneered by a team led by Professor ... Professor Lin is currently the exclusive collabor...
(Date:11/30/2009)...YORK, Nov. 30 Reportlinker.com ann...ble in its catalogue: ,, Diabetes Diagnostics ...eportlinker.com/p0164347/Diabetes-Diagnostics---A-...agnosis market is driven by a steady increase in t...in the developed and developing parts of the world...
Breaking Medicine Technology:MedQuist Features SpeechQ VTB for Radiology Solution at RSNA Convention 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 3Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 2Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 3Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 4Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 5Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 6Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 7Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 8Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 9Top Five International Pharmaceutical Company Awards Comprehensive Cardiac Safety Study to iCardiac 61111 1Top Five International Pharmaceutical Company Awards Comprehensive Cardiac Safety Study to iCardiac 61111 2realbuzz com Top Tips to Cut the Calories This Christmas Party Season 61108 1realbuzz com Top Tips to Cut the Calories This Christmas Party Season 61108 2Worksite wellness programs may reduce employee absenteeism 61107 1Worksite wellness programs may reduce employee absenteeism 61107 2
... ROCK, Ark., Oct. 8 A research study,at the Unive...esigned to,establish one of the largest and most r...dy of breast cancer occurrence. Spit for the Cure...ousands of women and is being conducted with the s...or the Cure. The saliva samples will be used to,cr...
...A, Oct. 8 Alimera Sciences Inc., a privately held...mited (Nasdaq: PSDV; ASX:,PSD; Xetra: PSI), announ...(TM) (Fluocinolone Acetonide in Diabetic Macular E... Diabetic Macular Edema. FAME is a,double masked, ...ver 900,patients in the U.S., Canada, Europe and I...
Other Medicine Technology:Spit for the Cure Offers Unique Opportunity for Women to Participate in Breast Cancer Research 2Enrollment Complete in Pivotal Phase 3 Trial of Medidur(TM) FA for Diabetic Macular Edema 2Enrollment Complete in Pivotal Phase 3 Trial of Medidur(TM) FA for Diabetic Macular Edema 3Enrollment Complete in Pivotal Phase 3 Trial of Medidur(TM) FA for Diabetic Macular Edema 4
...System is a long term, quality solution based on a...rior stabilized and anatomically correct cruciate ...rovides the flexibility needed to address patients...nd ease of identification keeps the user in mind a...
...l Iso-C3D C-Arm imaging system interface sets a ne...Combining mobility and accurate imaging with Medtr...technologies deliver the most complete perspective...e new standard in the OR. Medtronic-SNT has taken...
OmniSight image guided surgery system with Calyx 2 Fluoroscopic Tracking Module
...ents are the next evolution in transforaminal lumb...e and functionally sound instruments.. The T.L.I.F...moval and disc preparation instruments designed to... Excellent design, a wide range of instrument opti...
Medicine Products: